Inactief instrument

Andere talen Apexigen, Inc.

Aandelen

APGN

US03759B1026

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Apexigen, Inc.(NasdaqCM:APGN) dropped from S&P TMI Index	25-08-23
Pyxis Oncology Completes Acquisition of Apexigen	23-08-23
Apexigen, Inc.(NasdaqCM:APGN) dropped from NASDAQ Composite Index	23-08-23
Pyxis Oncology, Inc. completed the acquisition of Apexigen, Inc. from entities associated with Pfizer Inc., Lincoln Park Capital, LLC, managed by Laurion Capital Management LP, Bayer World Investments B.V. and others.	23-08-23
Apexigen, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10-08-23
APEXIGEN INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apexigen, Inc. - APGN	10-08-23
Apexigen Announces Phase 2 Data Evaluating Sotigalimab, its CD40 Agonist Antibody, in Combination with Doxorubicin in Patients with Advanced Soft Tissue Sarcoma Presented at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting	03-06-23
Apexigen, Inc. Announces Phase 2 Data Evaluating Sotigalimab, its CD40 Agonist Antibody, in Combination with Doxorubicin in Patients with Advanced Soft Tissue Sarcoma Presented at the American Society of Clinical Oncology 2023 Annual Meeting	03-06-23
APEXIGEN INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apexigen, Inc. - APGN	31-05-23
North American Morning Briefing : Nvidia Surge -2-	25-05-23
Shareholder Alert: Ademi LLP investigates whether Apexigen, Inc. has obtained a Fair Price in its transaction with Pyxis Oncology	24-05-23
Wall Street Set to Open Lower as Investors Await Progress on Debt-Ceiling Talks Ahead of Fed Minutes Release	24-05-23
Sector Update: Health Care Stocks Mixed Premarket Wednesday	24-05-23
Sector Update: Health Care	24-05-23
APGN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Apexigen, Inc. Is Fair to Shareholders	24-05-23
US Futures Lower as Investors Eye Debt Ceiling Talks, Await Fed Minutes Release	24-05-23
Top Premarket Gainers	24-05-23
Pyxis Oncology to Acquire Apexigen in $16 Million All-Stock Deal	24-05-23
Pyxis Oncology to Acquire Apexigen	24-05-23
Apexigen, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15-05-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Apexigen, Inc.

Aandelen

APGN

US03759B1026

Andere talen

Filters